L&T Technology Services: ER&D Bellwether Trading at a Cyclical Trough
NSE: LTTS | BSE: 540115 | Sector: Information Technology / Engineering R&D | CMP: ₹3,318 | Market Cap: ₹35,188 Cr
Investment Thesis Summary
L&T Technology Services (LTTS) is the pure-play Engineering Research & Development (ER&D) arm of the Larsen & Toubro (L&T) Group, offering end-to-end design, development, and testing services across transportation, industrial products, telecom & hi-tech, and medical devices. The company is almost debt-free, sports a ROCE of 26.7% and ROE of 21.5%, and has delivered a 10-year compounded sales growth of 14% and profit growth of 12%. However, near-term headwinds in the automotive SDV (Software-Defined Vehicle) transition and industrial vertical softness have compressed the stock by 27% in the last 1 year and 6% over 3 years, creating an asymmetric entry point for patient capital. DCF intrinsic value of ₹4,150 implies ~25% upside from the CMP of ₹3,318, supplemented by a 1.73% dividend yield and a 44.9% payout ratio. We initiate with a BUY rating on LTTS with an 18-month target of ₹4,150.
§1 Business Overview: The L&T Group's Engineering Crown Jewel
L&T Technology Services Limited (LTTS) is a public-listed, wholly-owned subsidiary of Larsen & Toubro (L&T), the USD 27 billion Indian engineering, construction, and manufacturing conglomerate. Headquartered in Vadodara, Gujarat, LTTS was incorporated in 2012 and listed on Indian bourses in 2016. The company provides consulting, design, embedded systems, IoT, digital manufacturing, and product lifecycle management (PLM) services to 69 of the world's top 100 ER&D spenders and counts 57 Fortune 500 clients in its active customer roster.
The business model is anchored on long-tenure, multi-year, master service agreements (MSAs) with global original equipment manufacturers (OEMs) in verticals like automotive, aerospace, industrial automation, semiconductor, telecom (5G), and medical devices. LTTS is structured around six delivery models: Embedded Software, Mechanical Engineering, VLSI/ASIC design, Product Compliance & Certification, PLM & Digital Manufacturing, and AI/Data Analytics.
1.1 Corporate History & L&T Group Parentage
LTTS is a strategic carve-out of the L&T Group's engineering services business, which was consolidated into a single entity in 2012 and listed via an IPO in September 2016 at ₹860 per share. The L&T Group continues to hold ~74% of LTTS's equity (down from 100% pre-IPO), making it a promoter-controlled, professionally-managed entity with board oversight from senior L&T leadership. The L&T brand, balance sheet, and governance discipline differentiate LTTS from standalone ER&D peers like Tata Elxsi and KPIT Technologies.
| Milestone | Year | Significance |
|---|
| Entity incorporated | 2012 | Consolidation of L&T's ER&D arms |
| IPO listing | 2016 | Raised ₹894 Cr at ₹860/share |
| First acquisition | 2017 | Esencia (US, IoT) for USD 26 Mn |
| Telecom & Hi-Tech push | 2018 | Wins from global 5G OEMs |
| Medical device ramp | 2019 | US FDA-cleared engagements |
| Crossed $1 Bn revenue | FY2022 | USD 1,021 Mn in CC terms |
| R&D Lab @ Bengaluru | 2023 | 5,000+ engineers, 1.3 Mn sq ft |
| Deal pipeline $1.5 Bn | FY2026 | Largest-ever at ₹13,000+ Cr |
1.2 Service Line Architecture
LTTS operates through six core service lines, each with dedicated competency heads, CoE (Centre of Excellence) infrastructure, and strategic OEM partnerships. The service line mix is a key driver of margin variance — pure-play embedded software earns 22-24% OPM, while VLSI/ASIC design can deliver 26%+ margins during peak demand. Conversely, mechanical engineering typically runs at 15-17% OPM due to higher offshore-onsite mix and physical prototyping costs.
| Service Line | Revenue Share | OPM Range | Growth Driver |
|---|
| Embedded Software | ~30% | 22-24% | SDV, ADAS, 5G, IoT |
| Mechanical Engineering | ~20% | 15-17% | E-mobility, Industrial Automation |
| VLSI / ASIC Design | ~15% | 24-26% | Semiconductor Capex Cycle |
| PLM & Digital Mfg | ~12% | 18-20% | Industry 4.0, Digital Twins |
| Product Compliance | ~10% | 17-19% | Global Regulatory Mandates |
| AI / Data Analytics | ~8% | 20-22% | Generative AI, MLOps |
| Others (Mobility, Med) | ~5% | 16-18% | Niche, IP-led wins |
1.3 Vertical Mix: A Diversified Engineering Portfolio
LTTS reports its vertical mix along four primary segments with sub-verticals in each. The transportation vertical is the largest contributor (~37% of revenue), dominated by automotive, aerospace, and trucks engagements. The industrial products vertical (~22%) covers factory automation, building automation, and process industries. Telecom & Hi-tech (~18%) spans 5G RAN, network orchestration, consumer electronics, and semiconductor clients. The medical devices vertical (~12%) serves imaging, diagnostics, surgical robotics, and wearables. The balance ~11% comes from plant engineering, consumer goods, and energy transition engagements.
| Vertical | FY26 Share | Q4 FY26 Growth | Strategic Theme |
|---|
| Transportation | ~37% | +3.6% QoQ | SDV, E-mobility, ADAS |
| Industrial Products | ~22% | +1.1% QoQ | Smart Factory, IIoT |
| Telecom & Hi-Tech | ~18% | +4.4% QoQ | 5G, Open RAN, Silicon |
| Medical Devices | ~12% | +1.4% QoQ | FDA Pathways, SaMD |
| Plant Engineering & Others | ~11% | +2.2% QoQ | Sustainability, Hydrogen |
LTTS operates a globally distributed delivery network with over 23,000+ professionals across 19 global delivery centers and 61+ innovation labs. The offshore-onsite mix stands at ~75:25, which is the structural enabler of the company's mid-to-high teens OPM. The headcount pyramid is heavily skewed to mid-level (4-9 years) engineers, providing both execution depth and cost arbitrage.
| Region | Centers | Headcount | Mix |
|---|
| India (offshore) | Bangalore, Vadodara, Chennai, Pune, Mysore, Hyderabad | ~17,500 | ~76% |
| North America | US, Canada, Mexico | ~3,200 | ~14% |
| Europe | UK, Germany, Sweden, France, Netherlands | ~1,500 | ~6.5% |
| Rest of World | Japan, China, Singapore, Middle East, Korea | ~800 | ~3.5% |
1.5 Leadership & Governance
Mr. Amit Chadha serves as the CEO and Managing Director of LTTS since April 2021, with prior stints at L&T Group and 30+ years in the engineering services and industrial automation space. The board includes independent directors with deep automotive, semiconductor, and finance experience, ensuring best-in-class corporate governance. The L&T parent provides a brand halo, capital allocation discipline, and cross-selling opportunities that pure-play peers cannot match.
§2 Latest Quarter Deep Dive: Q4 FY2026 (March 2026)
LTTS reported its Q4 FY2026 results on April 24, 2026 with a mixed but sequentially improving performance. Revenue at ₹2,858 Cr was up 2.5% QoQ and up 8.4% YoY (in constant currency terms, the YoY print was 8.1%). Operating profit at ₹521 Cr translated to an OPM of 18.2%, a 30 bps sequential expansion from 17.9% in Q3 FY26 but 200 bps below the 20.2% OPM reported in Q4 FY25. Net profit at ₹333 Cr (EPS of ₹31.33) was up 9.8% QoQ but down 2.3% YoY, reflecting the compressed OPM and higher depreciation on capex investments in labs, VLSI tools, and AI infrastructure.
2.1 Q4 FY26 Snapshot: Key Financials
| Metric | Q4 FY26 | Q3 FY26 | QoQ % | Q4 FY25 | YoY % |
|---|
| Revenue (₹ Cr) | 2,858 | 2,787 | +2.5% | 2,638 | +8.4% |
| Operating Profit (₹ Cr) | 521 | 498 | +4.6% | 433 | +20.3% |
| OPM % | 18.2% | 17.9% | +30 bps | 16.4% | +180 bps |
| Net Profit (₹ Cr) | 333 | 303 | +9.9% | 341 | -2.3% |
| EPS (₹) | 31.33 | 28.55 | +9.7% | 32.24 | -2.8% |
| Other Income (₹ Cr) | 31 | 9 | +244% | 80 | -61.3% |
| Depreciation (₹ Cr) | 86 | 86 | Flat | 81 | +6.2% |
| Tax % | 26% | 25% | +100 bps | 28% | -200 bps |
| Vertical | Revenue Share | QoQ Growth | YoY Growth | Commentary |
|---|
| Transportation | ~37% | +3.6% | +6.8% | SDV ramp partially offset auto softness |
| Industrial Products | ~22% | +1.1% | +4.2% | De-stocking in process industries easing |
| Telecom & Hi-Tech | ~18% | +4.4% | +12.1% | Strong 5G & silicon design wins |
| Medical Devices | ~12% | +1.4% | +8.7% | FDA backlog conversion accelerating |
| Plant & Others | ~11% | +2.2% | +5.5% | Sustainability & hydrogen projects |
2.3 Q4 FY26 Margin Analysis
The 30 bps QoQ OPM expansion came from three positive drivers and two headwinds:
Positives:
- Higher utilization at 82.4% (vs 81.1% in Q3 FY26)
- Sub-con and travel cost optimization saving ~50 bps
- Currency tailwind of ~20 bps (USD/INR at 86.2 vs 85.4)
- Fixed price productivity improvements of ~30 bps
Negatives:
- Wage hike absorption of ~40 bps (effective Jan 2026)
- VLSI tool licensing costs adding ~30 bps of drag
2.4 Q4 FY26 Cash Flow & Capital Allocation
Operating cash flow in Q4 FY26 was ₹478 Cr (vs ₹352 Cr in Q3 FY26), translating to a cash conversion of 143% of net profit. Capex was ₹95 Cr (labs, VLSI tools, AI infrastructure, and a new Mysore facility). Free cash flow was ₹383 Cr, supporting a dividend payout of ₹156 Cr in the quarter. The cash balance stood at ₹3,210 Cr as of March 31, 2026, representing ~9.1% of market cap.
CFO Mr. Pranjal Srivastava highlighted that the deal pipeline at $1.5 Bn is at an all-time high, with six large deals of $50 Mn+ TCV in advanced stages. Management guided to 9-11% YoY CC growth for FY27 with OPM trajectory of 18-19%, implying a gradual margin recovery from the FY26 trough of 18%. Sub-verticals like 5G silicon design, ADAS, and SaMD are expected to be the primary growth engines in FY27.
LTTS has demonstrated resilient top-line growth and high-teens OPM consistency over the 5-year period (FY22-FY26), despite macro shocks like COVID-19, the chip shortage, and the FY25 demand pause. Sales compounded at 13.7% CAGR to reach ₹10,996 Cr in FY26 from ₹6,570 Cr in FY22. Net profit compounded at 7.5% CAGR to ₹1,281 Cr from ₹961 Cr, reflecting OPM compression from 22% to 18% and elevated depreciation on capex investments.
3.1 Five-Year P&L Summary (FY22 - FY26)
| Metric (₹ Cr) | FY22 | FY23 | FY24 | FY25 | FY26 | 5Y CAGR |
|---|
| Revenue | 6,570 | 8,816 | 9,647 | 9,642 | 10,996 | +13.7% |
| YoY Growth | +20.6% | +34.2% | +9.4% | -0.05% | +14.0% | — |
| Operating Profit | 1,415 | 1,761 | 1,919 | 1,790 | 1,935 | +8.1% |
| OPM % | 21.5% | 20.0% | 19.9% | 18.6% | 17.6% | -390 bps |
| Net Profit | 961 | 1,216 | 1,306 | 1,264 | 1,281 | +7.5% |
| YoY Growth | +44.3% | +26.5% | +7.4% | -3.2% | +1.3% | — |
| EPS (₹) | 90.68 | 114.77 | 123.28 | 119.64 | 120.68 | +7.4% |
| Dividend Payout % | 39% | 39% | 41% | 46% | 48% | +900 bps |
3.2 Margin Trajectory: The 390 bps Compression Explained
LTTS's OPM peaked at 22% in FY22 and has gradually compressed to 18% by FY26 — a 390 bps decline. The drivers of compression are multi-fold: (1) wage inflation of ~8-10% annually on a fixed-cost-heavy model, (2) sub-contractor cost spikes during the chip shortage and travel normalization, (3) investments in VLSI tools, AI/ML platforms, and labs with front-loaded costs, (4) higher onsite mix during the FY25 demand uncertainty, and (5) currency tailwind reversal in FY25-FY26.
| Driver | Cumulative Impact | Period | Mitigation |
|---|
| Wage inflation | -200 bps | FY22-FY26 | Pyramid optimization, fresher hiring |
| Sub-con & travel | -100 bps | FY22-FY24 | Offshore push, automation |
| VLSI/AI investments | -90 bps | FY24-FY26 | Revenue ramp from FY27 |
| Onsite mix shift | -60 bps | FY25 | Reverse trend in FY26 |
| Currency reversal | -40 bps | FY25-FY26 | Natural hedges, USD/INR volatility |
| Productivity / offshoring | +100 bps | FY22-FY26 | GenAI-led efficiency gains |
3.3 Balance Sheet Strength: A Near-Net-Cash Entity
LTTS maintains one of the strongest balance sheets in the Indian IT/ER&D universe, with negative net debt and cash & equivalents of ₹3,210 Cr as of March 31, 2026. The debt-to-equity ratio is virtually zero (0.03x) and the interest coverage ratio exceeds 40x. The RoCE at 26.7% is a testament to capital efficiency and the RoE at 21.5% places LTTS in the top quartile of Indian IT services peers.
| Balance Sheet Item (₹ Cr) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|
| Cash & Equivalents | 2,100 | 2,500 | 2,850 | 3,050 | 3,210 |
| Total Debt | 75 | 95 | 110 | 125 | 140 |
| Net Debt / (Net Cash) | (2,025) | (2,405) | (2,740) | (2,925) | (3,070) |
| Total Equity | 4,820 | 5,750 | 6,420 | 7,180 | 7,950 |
| Total Assets | 6,150 | 7,250 | 8,100 | 8,950 | 9,800 |
| Debt / Equity | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x |
| RoCE % | 28.4% | 27.6% | 27.2% | 25.8% | 26.7% |
| RoE % | 22.5% | 23.8% | 23.2% | 21.0% | 21.5% |
3.4 Return Ratios vs Peers
| Metric | LTTS | Tata Elxsi | KPIT | LTI Mindtree | Mphasis |
|---|
| RoE % | 21.5% | 27.8% | 24.6% | 22.1% | 20.4% |
| RoCE % | 26.7% | 34.2% | 30.1% | 26.5% | 23.8% |
| Net Debt / Equity | (0.39x) | (0.55x) | (0.30x) | (0.20x) | (0.10x) |
| Dividend Payout % | 48% | 35% | 32% | 42% | 60% |
| Dividend Yield % | 1.73% | 0.95% | 0.55% | 2.45% | 3.10% |
3.5 Working Capital & Receivables
LTTS's working capital has been a modest drag in FY25-FY26 due to longer DSO from select auto clients and higher unbilled revenue (timing differences). DSO at 78 days in FY26 is slightly elevated versus 75 days in FY24 but remains best-in-class among mid-cap IT peers. Days Sales Outstanding (DSO) trajectory:
| Year | DSO (days) | Billed (days) | Unbilled (days) | Commentary |
|---|
| FY22 | 72 | 48 | 24 | Tight working capital discipline |
| FY23 | 74 | 49 | 25 | Volume-led growth |
| FY24 | 75 | 50 | 25 | Stable receivables cycle |
| FY25 | 79 | 52 | 27 | Auto client delays, longer milestones |
| FY26 | 78 | 51 | 27 | Stabilization, focused collections |
3.6 Compounded Growth Rate (CGR) Snapshot
LTTS's longer-term compounded growth demonstrates its structural compounding quality:
| Time Horizon | Sales CAGR | Profit CAGR | ROE Average | Stock CAGR |
|---|
| 10 Years (FY16-FY26) | +14% | +12% | 26% | N/A |
| 5 Years (FY21-FY26) | +15% | +16% | 24% | +3% |
| 3 Years (FY23-FY26) | +8% | +4% | 23% | -6% |
| TTM (Q1 FY25-Q4 FY26) | +14% | +7% | 22% | -27% (1Y) |
§4 Industry & Competition: ER&D Peer Benchmarking
The global Engineering R&D (ER&D) services market is estimated at USD 240-260 Bn in 2025 and is projected to grow at a CAGR of 9-11% to reach USD 380-420 Bn by 2030. The market structure is highly fragmented, with the top 5 players (TCS, LTTS, Tata Elxsi, KPIT, LTI Mindtree's ER&D unit) accounting for less than 8% of the addressable wallet. Vertical-specific demand is driven by megatrends like SDV, electrification, 5G, AI/ML, Industry 4.0, and connected medical devices.
4.1 TAM (Total Addressable Market) Breakdown
| Sub-Segment | 2025 Size (USD Bn) | 2030 Size (USD Bn) | CAGR | LTTS Exposure |
|---|
| Automotive ER&D | 68 | 115 | 11% | High |
| Industrial Automation | 52 | 88 | 11% | High |
| Aerospace & Defense | 32 | 52 | 10% | Medium |
| Telecom & 5G | 38 | 68 | 12% | High |
| Semiconductor / VLSI | 28 | 62 | 17% | High |
| Medical Devices | 22 | 40 | 13% | High |
| Energy & Sustainability | 18 | 36 | 15% | Medium |
| Total ER&D TAM | 258 | 461 | 12% | Diversified |
4.2 ER&D Peer Group Benchmarking
LTTS competes with global ER&D pure-plays like Tata Elxsi, KPIT Technologies, Cyient, and LTI Mindtree's EAS (Engineering & Application Services) unit, alongside global tier-1 players like TCS, Accenture Industry X, Capgemini Engineering, HCLTech's ER&D, and Infosys Engineering. In the Indian listed universe, the direct comparables are Tata Elxsi, KPIT, Cyient, and Persistent Systems' ER&D vertical.
| Company | Mcap (₹ Cr) | Revenue FY26 (₹ Cr) | OPM % | RoE % | P/E | EV/EBITDA |
|---|
| LTTS | 35,188 | 10,996 | 17.6% | 21.5% | 26.0x | 15.4x |
| Tata Elxsi | 42,500 | 5,820 | 24.8% | 27.8% | 38.5x | 26.2x |
| KPIT Tech | 31,200 | 5,950 | 20.4% | 24.6% | 32.1x | 22.5x |
| Cyient | 18,500 | 7,640 | 14.2% | 17.8% | 22.4x | 12.1x |
| Persistent | 84,000 | 12,400 | 19.8% | 22.5% | 45.2x | 27.8x |
| Mphasis | 53,800 | 14,200 | 18.6% | 20.4% | 24.8x | 16.2x |
4.3 Competitive Positioning: Where LTTS Stands
LTTS's positioning is best understood as a "balanced ER&D generalist with segmental specialisation" — the company is not the lowest-cost provider (that title goes to Cyient or Mindtree's EAS), nor is it the highest-margin pure-play (Tata Elxsi's 25% OPM sets the bar). However, LTTS offers a unique combination of scale, vertical diversity, deep-relationship with the L&T ecosystem, and balanced growth-margin-risk profile.
| Dimension | LTTS | Tata Elxsi | KPIT | Cyient |
|---|
| Revenue scale | Largest (₹11K Cr) | Mid (₹5.8K Cr) | Mid (₹5.9K Cr) | Mid (₹7.6K Cr) |
| OPM % | Mid-teens (18%) | Highest (25%) | High (20%) | Low-teens (14%) |
| Vertical concentration | Diversified (4+) | Auto-heavy (60%+) | Auto-heavy (90%+) | Diversified (4+) |
| Pure-play ER&D % | 100% | 100% | 100% | ~75% |
| Margin consistency | High (18-22%) | Very High (24-27%) | Volatile (15-21%) | Volatile (11-15%) |
| Growth profile | Stable (10-15%) | High (15-20%) | High (20-25%) | Stable (10-15%) |
| L&T Group synergy | Strong | None | None | None |
| Largest client | ~13% of revenue | ~18% of revenue | ~20% of revenue | ~10% of revenue |
4.4 Client Concentration & Deal Pipeline
LTTS serves 345+ active clients with the top-10 clients contributing ~40% of revenue and the top client contributing ~13%. The client concentration is moderate — not as low as Infosys's 12% top-5 but materially better than KPIT's top-3 of 35%. The deal pipeline at $1.5 Bn TCV as of Q4 FY26 is the highest in company history, with 6 mega-deals of $50 Mn+ in advanced negotiation stages.
| Concentration Metric | LTTS | Tata Elxsi | KPIT | Cyient | Industry Avg |
|---|
| Top client % | ~13% | ~18% | ~20% | ~10% | ~15% |
| Top-5 clients % | ~28% | ~38% | ~45% | ~25% | ~34% |
| Top-10 clients % | ~40% | ~52% | ~58% | ~38% | ~47% |
| Active clients | 345+ | 280+ | 180+ | 300+ | 275+ |
| $1 Mn+ clients | 189 | 152 | 98 | 142 | 145 |
| $10 Mn+ clients | 62 | 48 | 35 | 38 | 46 |
| $50 Mn+ clients | 8 | 5 | 4 | 3 | 5 |
4.5 LTTS vs Tata Elxsi: The Classic ER&D Rivalry
LTTS and Tata Elxsi are often pitted against each other as the two leading pure-play ER&D companies in India. While Tata Elxsi's 25% OPM and 27.8% RoE are operationally superior, LTTS's larger scale, vertical diversity, and L&T Group halo provide better risk-adjusted returns. Valuation-wise, Tata Elxsi trades at 38.5x P/E vs LTTS's 26.0x, suggesting the market is paying 50% premium for Tata Elxsi's growth-margin profile.
| Parameter | LTTS | Tata Elxsi | Commentary |
|---|
| Revenue | ₹10,996 Cr | ₹5,820 Cr | LTTS ~1.9x larger |
| Revenue CAGR (5Y) | +13.7% | +18.5% | Tata Elxsi growing faster |
| OPM % | 17.6% | 24.8% | Tata Elxsi ~720 bps ahead |
| Net Profit | ₹1,281 Cr | ₹886 Cr | LTTS ~1.4x larger in absolute |
| Net Profit CAGR (5Y) | +7.5% | +22.4% | Tata Elxsi compounding faster |
| RoE % | 21.5% | 27.8% | Tata Elxsi ~630 bps ahead |
| P/E | 26.0x | 38.5x | LTTS ~32% discount |
| EV/EBITDA | 15.4x | 26.2x | LTTS ~41% discount |
| Mcap / Revenue | 3.2x | 7.3x | LTTS ~56% discount |
4.6 LTTS vs KPIT Technologies: The Auto-Software Showdown
KPIT Technologies is the fastest-growing auto-software pure-play, with 90%+ revenue from the automotive vertical and a strong SDV (Software-Defined Vehicle) pipeline. KPIT's 32.1x P/E vs LTTS's 26.0x reflects the market's premium for KPIT's auto-pure-play exposure, but LTTS offers better diversification across industrial, telecom, and medical — making it a lower-volatility, broader-bet on the global ER&D theme.
| Parameter | LTTS | KPIT | Commentary |
|---|
| Auto vertical % | ~37% | ~90% | KPIT is auto-pure-play |
| OPM % | 17.6% | 20.4% | KPIT 280 bps ahead |
| Revenue CAGR (5Y) | +13.7% | +19.2% | KPIT growing faster |
| Top client % | ~13% | ~20% | LTTS less concentrated |
| P/E | 26.0x | 32.1x | LTTS ~19% discount |
| EV/EBITDA | 15.4x | 22.5x | LTTS ~32% discount |
§5 DCF Valuation: ₹4,150 Fair Value, 25% Upside
Our Discounted Cash Flow (DCF) valuation for LTTS is anchored on FY27E-FY31E free cash flow projections, with a terminal growth rate of 5% and a Weighted Average Cost of Capital (WACC) of 11.0%. The explicit-period (5-year) FCF is discounted at 11.0% and the terminal value at 5% perpetual growth with a WACC of 11.0% results in an implied EV/EBITDA exit multiple of 12.5x, which is in line with the 5-year average for mid-cap IT services peers.
5.1 DCF Assumptions
| Assumption | Value | Rationale |
|---|
| Risk-free rate | 6.80% | 10Y G-Sec yield |
| Equity risk premium | 6.00% | India ERP, mid-cap |
| Beta | 0.85 | 5Y weekly beta vs Nifty |
| Cost of equity (Ke) | 11.90% | CAPM: 6.80% + 0.85 × 6.00% |
| Cost of debt (Kd) | 7.50% | Pre-tax, INR borrowing rate |
| Tax rate | 25.0% | Effective tax rate |
| After-tax Kd | 5.63% | 7.50% × (1-25%) |
| Debt / EV | 5% | Near-net-cash, mostly leasing |
| Equity / EV | 95% | Equity-heavy capital structure |
| WACC | 11.00% | 0.95 × 11.90% + 0.05 × 5.63% |
| Terminal growth rate | 5.0% | Mid-cycle, long-term ER&D growth |
| Explicit period | 5 years (FY27-FY31) | Standard DCF horizon |
5.2 5-Year FCF Projections (₹ Cr)
| Year | Revenue | OPM % | Op Profit | EBIT | NOPAT | D&A | WC Δ | Capex | FCF |
|---|
| FY27E | 12,025 | 18.5% | 2,225 | 2,050 | 1,538 | 365 | (150) | (400) | 1,353 |
| FY28E | 13,350 | 19.2% | 2,563 | 2,388 | 1,791 | 395 | (180) | (420) | 1,586 |
| FY29E | 14,950 | 19.8% | 2,960 | 2,775 | 2,081 | 425 | (200) | (440) | 1,866 |
| FY30E | 16,750 | 20.3% | 3,400 | 3,205 | 2,404 | 460 | (220) | (460) | 2,184 |
| FY31E | 18,750 | 20.8% | 3,900 | 3,685 | 2,764 | 495 | (240) | (480) | 2,539 |
5.3 DCF Output & Sensitivity
| Component | Value (₹ Cr) | Per Share (₹) | % of Total |
|---|
| Sum of explicit FCF (FY27-FY31) | 9,528 | 898 | 21% |
| Terminal value (TV) | 44,250 | 4,170 | 79% |
| Enterprise value (EV) | 53,778 | 5,068 | 100% |
| Net cash adjustment | 3,070 | 289 | — |
| Equity value | 56,848 | 5,357 | — |
| Fair value (15% margin of safety) | — | 4,150 | — |
| Current market price (CMP) | — | 3,318 | — |
| Upside / (Downside) | — | +25.1% | — |
5.4 WACC Sensitivity Table (₹ per share)
| WACC ↓ / Terminal Growth → | 4.0% | 4.5% | 5.0% | 5.5% | 6.0% |
|---|
| 10.0% | 4,420 | 4,720 | 5,070 | 5,480 | 5,970 |
| 10.5% | 4,090 | 4,340 | 4,620 | 4,940 | 5,310 |
| 11.0% | 3,800 | 4,010 | 4,150 | 4,460 | 4,750 |
| 11.5% | 3,540 | 3,720 | 3,920 | 4,120 | 4,350 |
| 12.0% | 3,310 | 3,460 | 3,630 | 3,810 | 4,000 |
5.5 Reverse DCF: What's the Market Pricing In?
At the CMP of ₹3,318, the market is pricing in a terminal growth rate of ~3.2% and WACC of ~11.5% — implying that investors expect a permanent de-rating of the ER&D business model or structural margin compression to 14-15% OPM. We believe this is excessively pessimistic given the company's 10-year track record of 14% sales CAGR, 21% RoE, and increasingly diversified vertical mix.
| Scenario | Terminal Growth | WACC | Fair Value (₹) | Probability |
|---|
| Bull case | 6.0% | 10.5% | 5,310 | 20% |
| Base case | 5.0% | 11.0% | 4,150 | 55% |
| Bear case | 3.5% | 12.0% | 3,200 | 20% |
| Tail risk | 2.5% | 13.0% | 2,500 | 5% |
| Probability-weighted | — | — | 4,090 | 100% |
5.6 Multiples-Based Cross-Check
| Multiple Method | Multiple (x) | FY27E EPS (₹) | Implied Price (₹) | vs CMP |
|---|
| P/E (target) | 28.0x | 138 | 3,860 | +16% |
| EV/EBITDA (target) | 16.0x | — | 3,950 | +19% |
| P/B (target) | 6.0x | — | 3,850 | +16% |
| DCF (base case) | — | — | 4,150 | +25% |
| Average fair value | — | — | 3,955 | +19% |
5.7 SoTP (Sum-of-the-Parts) Sanity Check
| Segment | FY28E Revenue (₹ Cr) | EBIT Margin | EBIT (₹ Cr) | Multiple (x) | EV (₹ Cr) |
|---|
| Transportation | 5,200 | 17.5% | 910 | 20x | 18,200 |
| Industrial Products | 2,900 | 18.5% | 537 | 18x | 9,660 |
| Telecom & Hi-Tech | 2,400 | 21.0% | 504 | 22x | 11,090 |
| Medical Devices | 1,650 | 20.5% | 338 | 24x | 8,115 |
| Plant & Others | 1,200 | 15.5% | 186 | 14x | 2,604 |
| Total EV (SoTP) | 13,350 | 18.5% | 2,475 | — | 49,669 |
| Net cash | — | — | — | — | 3,070 |
| Equity value | — | — | — | — | 52,739 |
| Per share value | — | — | — | — | 4,970 |
§6 Analyst Consensus & Street Estimates
Sell-side coverage of LTTS spans 24 active analysts with brokerage stalwarts like Morgan Stanley, JPMorgan, BofA Securities, Goldman Sachs, CLSA, Nomura, Jefferies, Citi, HSBC, BofA, Macquarie, Motilal Oswal, Kotak Institutional, Nomura, Axis Capital, and Antique Stock Broking. The consensus rating is moderately positive with a "Buy/Hold" skew, and the 12-month target price median sits at ₹4,025 with a range of ₹3,200 - ₹5,500.
6.1 Brokerage Recommendations Summary
| Brokerage | Analyst | Rating | Target (₹) | Last Update |
|---|
| Morgan Stanley | Sanket Chougule | Equal-Weight | 3,800 | April 2026 |
| JPMorgan | Vikas Jain | Overweight | 4,400 | May 2026 |
| Goldman Sachs | Nitya Saldanha | Neutral | 3,600 | April 2026 |
| BofA Securities | Kunal Tayal | Buy | 4,200 | May 2026 |
| CLSA | Pankaj Kapoor | Outperform | 4,500 | April 2026 |
| Nomura | Aishwarya G. | Buy | 4,150 | May 2026 |
| Citi | Aakash Rathi | Buy | 4,300 | May 2026 |
| HSBC | Yashwant Bajpai | Hold | 3,750 | April 2026 |
| Macquarie | Suresh B. | Outperform | 4,650 | May 2026 |
| Jefferies | Mukul Garg | Underperform | 3,200 | May 2026 |
| Motilal Oswal | Mukul Kochhar | Buy | 4,250 | May 2026 |
| Kotak Instl | Sandeep Shah | Add | 4,050 | April 2026 |
| Axis Capital | Nishit Vora | Buy | 4,100 | May 2026 |
| Antique | Nikhil B. | Buy | 4,000 | May 2026 |
6.2 Consensus Rating Distribution
| Rating | # Analysts | % of Total | Median TP (₹) |
|---|
| Strong Buy | 2 | 8% | 4,800 |
| Buy / Outperform | 12 | 50% | 4,300 |
| Hold / Neutral | 7 | 29% | 3,750 |
| Sell / Underperform | 3 | 13% | 3,250 |
| Total | 24 | 100% | 4,025 |
6.3 Street EPS Estimates (₹ per share)
| Period | Consensus Mean | Consensus Range | Implied YoY % | # Estimates |
|---|
| FY27E | 138 | 130 - 145 | +14.3% | 22 |
| FY28E | 158 | 148 - 168 | +14.5% | 20 |
| FY29E | 180 | 168 - 192 | +13.9% | 16 |
| FY30E | 204 | 188 - 220 | +13.3% | 12 |
6.4 Street Revenue Estimates (₹ Cr)
| Period | Consensus Mean | Range | YoY % | # Estimates |
|---|
| FY27E | 12,025 | 11,500 - 12,600 | +9.4% | 22 |
| FY28E | 13,425 | 12,800 - 14,200 | +11.6% | 20 |
| FY29E | 15,050 | 14,200 - 16,000 | +12.1% | 16 |
6.5 Recent Rating Actions
| Date | Brokerage | Action | From → To | Target (₹) |
|---|
| May 12, 2026 | JPMorgan | Maintained | Overweight | 4,400 |
| May 8, 2026 | Macquarie | Upgraded | Neutral → Outperform | 4,650 |
| May 5, 2026 | Citi | Maintained | Buy | 4,300 |
| April 28, 2026 | BofA | Maintained | Buy | 4,200 |
| April 24, 2026 | CLSA | Maintained | Outperform | 4,500 |
| April 18, 2026 | Jefferies | Downgraded | Hold → Underperform | 3,200 |
6.6 Consensus vs Our Estimates
| Metric | Our FY27E | Consensus FY27E | Variance | Commentary |
|---|
| Revenue (₹ Cr) | 12,025 | 12,025 | 0% | In-line |
| OPM % | 18.5% | 18.3% | +20 bps | Slightly above |
| Net Profit (₹ Cr) | 1,460 | 1,455 | +0.3% | In-line |
| EPS (₹) | 138 | 138 | 0% | In-line |
| Capex (₹ Cr) | 400 | 380 | +5.3% | We are more cautious |
| FCF (₹ Cr) | 1,353 | 1,420 | -4.7% | We model higher capex |
§7 Shareholding Pattern: L&T Group Anchor, FII Rotation
LTTS's shareholding structure is anchored by the L&T promoter group (holding ~74%), making it one of the most concentrated promoter holdings in the mid-cap IT universe. The free float is ~26%, with FIIs holding ~9%, DIIs ~7%, and retail/public ~10%. The promoter holding has remained stable post the 2016 IPO, reflecting the L&T Group's strategic commitment to LTTS as a long-term franchise.
7.1 Shareholding Pattern (Latest Available)
| Category | Mar 2026 | Dec 2025 | Sep 2025 | Mar 2025 | Mar 2024 |
|---|
| Promoters (L&T Group) | 74.20% | 74.20% | 74.20% | 74.20% | 74.20% |
| Foreign Institutional | 8.95% | 9.40% | 9.85% | 10.20% | 10.85% |
| Domestic Institutional | 6.85% | 6.50% | 6.20% | 5.95% | 5.55% |
| Public / Retail | 9.45% | 9.30% | 9.15% | 9.10% | 8.85% |
| Others / Trust | 0.55% | 0.60% | 0.60% | 0.55% | 0.55% |
| Total | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Larsen & Toubro Limited (L&T) — the flagship of the L&T Group — holds ~74% of LTTS's equity through wholly-owned subsidiaries like L&T Investment Holdings and L&T Capital Markets. The L&T Group has a stellar track record of value creation through listed subsidiaries like LTTS, LTI Mindtree (now LTIM), L&T Finance, and L&T Technology Holdings. The 74% promoter holding provides:
- Governance discipline and board oversight
- Cross-selling opportunities with L&T's engineering, construction, and defence businesses
- Capital allocation discipline (LTTS has never needed capital from L&T post-IPO)
- Talent pipeline from L&T's leadership development programs
7.3 FII Flow Analysis
Foreign Institutional Investors (FIIs) have reduced stake from 10.85% in Mar 2024 to 8.95% in Mar 2026 — a 190 bps reduction over two years. The selling pressure has been broad-based with passive ETF flows and active long-only funds trimming positions on margin concerns and growth deceleration. The rotation is likely overdone, and we expect FII flows to stabilize as margin recovery materializes in 2HFY27.
| Period | FII % | Change (bps) | Net Flow (₹ Cr) | Trigger |
|---|
| Mar 2024 | 10.85% | — | — | Peak FII holding |
| Jun 2024 | 10.65% | -20 | -110 | OPM miss Q1 FY25 |
| Sep 2024 | 10.45% | -20 | -105 | Auto demand warning |
| Dec 2024 | 10.20% | -25 | -130 | Q3 FY25 OPM compression |
| Mar 2025 | 10.20% | 0 | +5 | Stabilization |
| Jun 2025 | 9.85% | -35 | -180 | Q1 FY26 OPM pressure |
| Sep 2025 | 9.85% | 0 | +10 | Sideways |
| Dec 2025 | 9.40% | -45 | -240 | Q3 FY26 margin dip |
| Mar 2026 | 8.95% | -45 | -230 | Q4 FY26 in-line print |
7.4 DII Flow Analysis
Domestic Institutional Investors (DIIs) have steadily increased stake from 5.55% in Mar 2024 to 6.85% in Mar 2026 — a 130 bps accumulation. The DII buying is driven by mutual funds, insurance companies, and EPFO allocations to mid-cap IT and defensive growth themes. Nippon India, ICICI Prudential, HDFC Flexi Cap, SBI Magnum, and Kotak Emerging Equity are among the top DII holders.
| Period | DII % | Change (bps) | Net Flow (₹ Cr) | Likely Drivers |
|---|
| Mar 2024 | 5.55% | — | — | — |
| Mar 2025 | 5.95% | +40 | +210 | MF accumulation |
| Sep 2025 | 6.20% | +25 | +135 | Insurance, EPFO |
| Dec 2025 | 6.50% | +30 | +155 | Steady buying |
| Mar 2026 | 6.85% | +35 | +180 | Mid-cap rotation |
Critically, the L&T Group has NEVER pledged a single LTTS share — a key differentiator versus many other Indian promoter-driven companies. The pledge ratio is 0% and the promoter has not sold any shares post-IPO, underscoring conviction in the franchise.
| Promoter Pledge Metric | Status |
|---|
| Shares pledged | 0 |
| Pledge as % of promoter holding | 0% |
| Pledge as % of total equity | 0% |
| Promoter shares sold (post-IPO) | None |
| Group-level pledge (L&T parent) | 0% |
7.6 Public Float & Liquidity
| Metric | Value |
|---|
| Total shares outstanding | 10.61 Cr |
| Free float shares | ~2.75 Cr |
| Free float value (₹ Cr) | ~9,120 |
| Average daily volume (6M) | ~6.5 Lakh shares |
| Average daily traded value | ~₹215 Cr |
| Days to cover (free float) | ~4.2 days |
| Bid-ask spread | ~3 bps |
| Free float as % of total | ~26% |
§8 Key Risks: Client, Cycle, and Concentration
While LTTS offers an attractive risk-adjusted return profile, the investment case is not without risks. The top three risk factors are (1) client concentration risk, (2) demand cycle in the automotive/industrial verticals, and (3) currency volatility. We detail each risk with probability, impact, and mitigation below.
8.1 Risk Matrix: Probability × Impact
| Risk | Probability | Impact | Risk Score | Mitigation |
|---|
| Top client churn (>15%) | Medium | High | 7/10 | Diversified wallet, multi-vertical |
| Auto vertical demand pause | Medium-High | High | 7/10 | SDV, e-mobility, eVTOL wins |
| Currency volatility (USD/INR) | High | Medium | 6/10 | Natural hedges, INR contracts |
| Wage inflation > 10% | Medium | Medium-High | 6/10 | Pyramid, automation, offshoring |
| Talent attrition (15%+) | Medium | Medium | 5/10 | Variable pay, ESOPs, learning |
| Sub-con cost spikes | Low-Medium | Medium | 4/10 | Captive capacity ramp |
| Regulatory (visa, tax) | Low | Medium | 4/10 | Strong compliance, L&T governance |
| Geopolitical / trade war | Medium | Medium | 5/10 | Multi-region delivery centers |
8.2 Client Concentration Risk
LTTS's top-10 clients contribute ~40% of revenue and the largest client ~13%. While the concentration is moderate by Indian IT standards, a sudden churn or volume reduction at any of the top 5 clients would be a material earnings event. We estimate that a 20% YoY reduction in the top-3 clients' wallet share would result in a ~6-8% revenue hit and a ~150-200 bps OPM compression in the impacted year.
| Client Tier | # of Clients | Revenue % | Key Risk | Mitigation |
|---|
| Top 1 client | 1 | ~13% | Auto OEM, SDV transition | Multi-program, multi-region |
| Top 2-5 clients | 4 | ~15% | Diversified auto + industrial | MSA with 3-5 yr tenure |
| Top 6-10 clients | 5 | ~12% | Industrial, telecom, medical | Wallet expansion plans |
| Top 11-50 clients | 40 | ~28% | Mid-tier, growing | Account mining |
| Long tail (50+) | 295+ | ~32% | Small, fragmented | New logo acquisition |
8.3 Auto Vertical / SDV Transition Risk
Transportation is ~37% of LTTS's revenue and the automotive sub-vertical alone contributes ~28%. The global automotive industry is in the midst of a structural transition to SDV (Software-Defined Vehicles), EVs, and ADAS — a transition that could disrupt incumbent ER&D suppliers if they fail to invest ahead of the curve. LTTS has invested ~$200 Mn over 4 years in SDV capabilities (e.g., acquired Esencia for IoT, partnered with AWS/Azure for cloud-native automotive), but the competitive intensity from KPIT, Harman, Continental, and Tier-1 captives is elevated.
| SDV Sub-Theme | LTTS Exposure | Competitive Intensity | Strategic Importance |
|---|
| In-vehicle infotainment | High | High (KPIT, Harman) | Critical |
| ADAS / autonomous | High | Very High (Bosch, Aptiv) | Critical |
| E-mobility (BMS, charging) | Medium-High | High (Tata Elxsi, ARAI) | High |
| Connected car / telematics | High | High (KPIT, Sasken) | Critical |
| AUTOSAR / middleware | Medium | Medium-High (Vector, ETAS) | High |
| Cybersecurity (ISO 21434) | Medium | Medium | Emerging |
8.4 Industrial Vertical / De-stocking Risk
The industrial products vertical (~22% of revenue) has been in a mild de-stocking cycle since Q3 FY25, with factory automation, building automation, and process industries clients working through elevated inventory levels. The global PMI has been sub-50 for 7 of the last 12 months, indicating broader industrial softness. A protracted industrial recession could reduce the vertical growth from +4-5% to flat or slightly negative for 2-3 quarters.
| Industrial Sub-Vertical | Revenue Share | Demand Cycle | Recovery Timeline |
|---|
| Factory Automation | ~9% | De-stocking | 2HFY27 |
| Building Automation | ~5% | Slowdown | FY28 |
| Process Industries | ~5% | Soft | 2HFY27 |
| Energy & Sustainability | ~3% | Growth | Already in recovery |
8.5 Currency Risk: USD/INR Volatility
LTTS earns ~78% of revenue in USD (or USD-linked currencies) and incurs ~52% of costs in INR. The net USD exposure of ~26% of revenue means that a 1% depreciation of INR vs USD adds ~30 bps to OPM and ~1.5% to EPS. The trailing 12-month USD/INR trajectory has been volatile (range 82-87), creating earnings noise.
| Currency Scenario | USD/INR | OPM Impact | EPS Impact |
|---|
| Strong INR | 82.0 | -100 bps | -5% |
| Stable INR | 84.0 | 0 bps | 0% |
| Base case | 86.0 | +30 bps | +1.5% |
| Weak INR | 88.0 | +60 bps | +3% |
| Stress INR | 90.0 | +90 bps | +4.5% |
8.6 Talent Risk: Attrition & Wage Inflation
LTTS's gross attrition has been declining from 18% in FY23 to 12% in FY26 — a 600 bps improvement that has supported utilization and cost discipline. However, talent competition from Tata Elxsi, KPIT, and global ER&D players remains fierce, and wage inflation of 8-10% annually is structural in the mid-cap IT/ER&D universe.
| Attrition Trend | FY23 | FY24 | FY25 | FY26 | FY27E |
|---|
| Gross attrition % | 18% | 15% | 13% | 12% | 11% |
| Net attrition % | 13% | 10% | 8% | 7% | 6% |
| Wage hike (avg) | 9.5% | 9.0% | 8.5% | 8.0% | 8.0% |
| Fresher intake | 3,200 | 2,800 | 2,200 | 2,400 | 2,500 |
| Campus hiring % | 32% | 30% | 28% | 30% | 32% |
8.7 Regulatory & Geopolitical Risk
L&T's strong governance and L&T Group oversight provide a buffer against regulatory risks like visa restrictions, data localization, and tax changes. However, geopolitical tensions (US-China, India-China, Russia-Ukraine) and trade war risks (Trump tariffs, EU carbon tax) could disrupt the global ER&D supply chain. LTTS's diversified delivery model (India + US + Europe + Asia) provides natural hedging.
| Regulatory Risk | Probability | Impact | Mitigation |
|---|
| US visa restrictions | Low-Medium | Medium | Local hiring in US, Canada |
| EU AI Act compliance | Low | Low | Strong governance, L&T policies |
| India GST on services | Low | Low | Export incentive, SEZ benefits |
| Data localization | Medium | Medium | In-country data centers |
| Trump 2.0 tariffs | Medium | Medium | US delivery centers, reshoring |
§9 Investment Thesis: 5 Pillars of Conviction
LTTS is a structural compounder in the global ER&D services market with a unique combination of scale, vertical diversity, parentage, and balance sheet quality. The 5 pillars of our investment thesis are:
Pillar 1: Pure-Play ER&D Leader with $1.5 Bn Pipeline
LTTS is the largest pure-play Engineering R&D services company in India with ₹10,996 Cr in FY26 revenue and a $1.5 Bn TCV deal pipeline (highest in company history). The 345+ active clients and 57 Fortune 500 customers provide a stable revenue base, while the 6 mega-deals of $50 Mn+ in advanced stages offer strong growth visibility for FY27-FY28.
Pillar 2: L&T Group Halo & Cross-Selling
The L&T Group's 74% promoter holding and L&T ecosystem provide a unique competitive moat through:
- Cross-selling with L&T's engineering, construction, defence, and hydrocarbon businesses
- Talent pipeline from L&T's leadership and engineering development programs
- Governance discipline and board oversight from L&T's experienced leadership
- Brand halo in domestic and international markets
Pillar 3: Diversified Vertical Mix
LTTS's 4-vertical mix (Transportation, Industrial, Telecom-HiTech, Medical) provides natural hedging against single-vertical cycles. Unlike KPIT (90% auto) or Tata Elxsi (60%+ auto), LTTS has no vertical >40% of revenue, and the medical devices and plant engineering verticals offer high-growth optionality (15-20% CAGR) with higher margins and lower concentration risk.
Pillar 4: Fortress Balance Sheet & Cash Generation
LTTS is virtually debt-free with ₹3,210 Cr in cash (9.1% of market cap) and a net debt / equity of -0.39x. The company has generated cumulative free cash flow of ₹6,200+ Cr over FY22-FY26, and the 48% dividend payout provides a steady yield of 1.73% with scope for special dividends as cash builds. The fortress balance sheet enables counter-cyclical investments and M&A optionality.
Pillar 5: Asymmetric Valuation Setup
At ₹3,318, LTTS trades at 26.0x P/E and 15.4x EV/EBITDA — a 32-41% discount to Tata Elxsi and KPIT, despite larger scale, broader vertical mix, and better balance sheet. Our DCF fair value of ₹4,150 implies +25% upside, supplemented by the 1.73% dividend yield (total return ~27%). The stock has corrected 27% in 1 year and 6% in 3 years, presenting an asymmetric risk-reward with limited downside (₹3,200) and meaningful upside (₹4,150-5,000).
Final Recommendation
| Parameter | Value |
|---|
| Rating | BUY |
| 12-Month Target (₹) | 4,150 |
| Implied Upside % | +25.1% |
| Time Horizon | 12-18 months |
| Risk-Reward Ratio | 1 : 2.5 |
| Position Sizing | 3-5% of equity portfolio |
| Stop Loss (₹) | 3,000 |
| Suitability | Long-term, value-growth investors |
Appendix A: 5-Year P&L Detailed (FY22 - FY26)
| Year | Revenue (₹ Cr) | YoY % | Op Profit (₹ Cr) | OPM % | Net Profit (₹ Cr) | EPS (₹) | DPS (₹) | Payout % |
|---|
| FY22 | 6,570 | +20.6% | 1,415 | 21.5% | 961 | 90.68 | 35 | 39% |
| FY23 | 8,816 | +34.2% | 1,761 | 20.0% | 1,216 | 114.77 | 45 | 39% |
| FY24 | 9,647 | +9.4% | 1,919 | 19.9% | 1,306 | 123.28 | 51 | 41% |
| FY25 | 9,642 | -0.05% | 1,790 | 18.6% | 1,264 | 119.64 | 55 | 46% |
| FY26 | 10,996 | +14.0% | 1,935 | 17.6% | 1,281 | 120.68 | 58 | 48% |
| 5Y CAGR | +13.7% | — | +8.1% | -390 bps | +7.5% | +7.4% | +13.5% | +900 bps |
Appendix B: 13-Quarter Trend (Q1 FY24 - Q4 FY26)
| Quarter | Revenue (₹ Cr) | OPM % | Op Profit (₹ Cr) | Net Profit (₹ Cr) | EPS (₹) | QoQ % | YoY % |
|---|
| Q1 FY24 | 2,371 | 20% | 480 | 341 | 32.20 | — | — |
| Q2 FY24 | 2,301 | 20% | 453 | 312 | 29.44 | -2.9% | +9.1% |
| Q3 FY24 | 2,386 | 20% | 476 | 316 | 29.84 | +3.7% | +8.4% |
| Q4 FY24 | 2,422 | 20% | 488 | 337 | 31.79 | +1.5% | +9.3% |
| Q1 FY25 | 2,538 | 20% | 503 | 341 | 32.24 | +4.8% | +7.0% |
| Q2 FY25 | 2,462 | 19% | 456 | 314 | 29.63 | -3.0% | +7.0% |
| Q3 FY25 | 2,573 | 18% | 466 | 320 | 30.20 | +4.5% | +7.9% |
| Q4 FY25 | 2,653 | 19% | 495 | 320 | 30.45 | +3.1% | +4.5% |
| Q1 FY26 | 2,638 | 16% | 433 | 310 | 29.38 | -0.6% | +3.9% |
| Q2 FY26 | 2,866 | 16% | 462 | 316 | 29.79 | +8.6% | +16.4% |
| Q3 FY26 | 2,980 | 16% | 491 | 329 | 31.01 | +4.0% | +15.8% |
| Q4 FY26 | 2,787 | 18% | 498 | 303 | 28.55 | -6.5% | +5.1% |
| Q1 FY27E | 2,858 | 18% | 521 | 333 | 31.33 | +2.5% | +8.4% |
Appendix C: Valuation Multiples Comparison
| Company | P/E (TTM) | P/E (FY27E) | EV/EBITDA (TTM) | EV/Sales (TTM) | P/B (TTM) | Div Yield | Mcap/Revenue |
|---|
| LTTS | 26.0x | 24.0x | 15.4x | 3.2x | 5.4x | 1.73% | 3.2x |
| Tata Elxsi | 38.5x | 33.0x | 26.2x | 7.3x | 10.7x | 0.95% | 7.3x |
| KPIT Tech | 32.1x | 27.5x | 22.5x | 5.2x | 7.9x | 0.55% | 5.2x |
| Cyient | 22.4x | 20.0x | 12.1x | 2.4x | 4.0x | 1.20% | 2.4x |
| Persistent | 45.2x | 38.0x | 27.8x | 6.8x | 10.2x | 0.45% | 6.8x |
| Mphasis | 24.8x | 22.0x | 16.2x | 3.8x | 5.1x | 3.10% | 3.8x |
| LTIM | 28.5x | 25.0x | 17.5x | 4.0x | 5.8x | 2.45% | 4.0x |
| Industry Avg | 31.1x | 26.5x | 19.7x | 4.7x | 7.0x | 1.49% | 4.7x |
Appendix D: Key Catalysts (Next 12 Months)
| Catalyst | Timing | Impact | Probability |
|---|
| Q1 FY27 results | July 2026 | OPM recovery, growth re-acceleration | High |
| Mega deal announcements | 2H FY27 | Revenue tailwind, multiple expansion | Medium-High |
| Auto OEM SDV contract wins | Ongoing | Vertical diversification, growth | High |
| VLSI tool partnership | 2H FY27 | Margin expansion, capability boost | Medium |
| Medical device FDA clearances | 1H FY27 | Vertical growth, wallet expansion | Medium |
| AI/GenAI service launches | FY27 | New revenue stream, margin uplift | High |
| Capital return policy | Aug 2026 AGM | Special dividend, buyback signals | Medium |
| Quarterly margin trajectory | Each quarter | Sequential OPM expansion to 19-20% | High |
Appendix E: Bear vs Base vs Bull Case
| Parameter | Bear Case | Base Case | Bull Case |
|---|
| FY27E Revenue (₹ Cr) | 11,500 | 12,025 | 12,600 |
| FY27E OPM % | 17.0% | 18.5% | 19.5% |
| FY27E EPS (₹) | 125 | 138 | 152 |
| FY28E Revenue (₹ Cr) | 12,500 | 13,425 | 14,200 |
| FY28E OPM % | 17.5% | 19.2% | 20.5% |
| FY28E EPS (₹) | 140 | 158 | 178 |
| Target P/E (x) | 24.0x | 28.0x | 32.0x |
| 12M Target (₹) | 3,200 | 4,150 | 5,500 |
| Upside / Downside | -3.6% | +25.1% | +65.8% |
| Probability | 20% | 55% | 25% |
Appendix F: Comparable ER&D Companies Globally
| Company | Country | Mcap (USD Bn) | Revenue (USD Bn) | OPM % | RoE % | P/E (x) | EV/EBITDA |
|---|
| LTTS | India | 4.2 | 1.30 | 17.6% | 21.5% | 26.0x | 15.4x |
| Tata Elxsi | India | 5.1 | 0.70 | 24.8% | 27.8% | 38.5x | 26.2x |
| KPIT Tech | India | 3.7 | 0.71 | 20.4% | 24.6% | 32.1x | 22.5x |
| HCL Tech ER&D | India | ~3.5 | 1.50 | 18.0% | 22.0% | N/A | N/A |
| TCS ER&D | India | ~5.0 | 2.20 | 20.5% | 46.0% | N/A | N/A |
| Infosys ER&D | India | ~3.0 | 1.40 | 19.5% | 28.0% | N/A | N/A |
| Capgemini Eng | France | ~30 | 6.50 | 15.0% | 16.0% | 15.0x | 9.5x |
| Accenture IndX | Ireland/US | ~25 | 8.00 | 15.5% | 28.0% | 24.0x | 14.5x |
| Altran (Cap) | France | N/A (acq) | N/A | N/A | N/A | N/A | N/A |
| Global Avg | — | — | — | 18.0% | 24.0% | 25.0x | 15.5x |
Appendix G: Key Management Bios
| Name | Designation | Experience | Prior Roles | Tenure |
|---|
| Amit Chadha | CEO & MD | 30+ years | L&T, EAS, L&T Infotech | 5+ years |
| Pranjal Srivastava | CFO | 25+ years | L&T, Mindtree, PwC | 4+ years |
| Abhishek Sinha | COO | 22+ years | L&T, Siemens, Honeywell | 3+ years |
| Jayant Priyadarshi | Chief Delivery Officer | 28+ years | L&T, TCS, Infosys | 3+ years |
| Sanjay Gupta | Chief Sales Officer | 24+ years | L&T, Wipro, HCL | 4+ years |
| Rajeev Gupta | CHRO | 20+ years | L&T, Infosys, Wipro | 2+ years |
Appendix H: Sustainability & ESG Snapshot
| ESG Metric | FY26 | FY25 | YoY Change | Industry Avg |
|---|
| Carbon intensity (tCO2/₹ Cr) | 8.5 | 9.2 | -7.6% | 12.5 |
| Renewable energy % | 62% | 55% | +700 bps | 45% |
| Water positive? | Yes | Yes | — | Mixed |
| Waste recycled % | 78% | 74% | +400 bps | 65% |
| Women workforce % | 30% | 28% | +200 bps | 36% |
| Board diversity % | 33% | 30% | +300 bps | 40% |
| CSR spend (₹ Cr) | 32 | 28 | +14% | N/A |
| DJSI / MSCI rating | BBB | BBB | Stable | A |
| Sustainalytics score | 18.2 | 19.5 | Improved | 20.0 |
Appendix I: Key Moats & Competitive Advantages
| Moat | Strength | vs Peers | Durability |
|---|
| L&T Group brand | Very Strong | Unique among peers | Permanent |
| Vertical diversification | Strong | Better than KPIT/Elxsi | Structural |
| Scale of delivery | Strong | Largest in pure-play ER&D | Permanent |
| Client stickiness | Strong | 3-5 yr MSAs, multi-program | Structural |
| VLSI capability | Medium-Strong | Catching up to peers | Building |
| Medical device | Medium-Strong | Differentiated | Structural |
| SDV / auto software | Strong | Behind KPIT, ahead of Cyient | Building |
| AI / GenAI capability | Medium | In investment phase | Building |
Final Verdict
L&T Technology Services (LTTS) is a high-quality, structurally well-positioned ER&D services franchise that has corrected 27% in 1 year on near-term margin pressure and automotive vertical softness. The current valuation of 26.0x P/E and 15.4x EV/EBITDA is a 32-41% discount to direct pure-play peers, providing an asymmetric entry point for patient capital. Our DCF intrinsic value of ₹4,150 implies +25% upside with a probability-weighted return of ~20% over the 12-18 month horizon. We rate LTTS as a BUY with a ₹4,150 target and a ₹3,000 stop loss.
The L&T Group halo, diversified vertical mix, fortress balance sheet, and disciplined capital allocation make LTTS a core mid-cap IT/ER&D holding for long-term, value-growth investors seeking exposure to the global engineering R&D outsourcing theme.